Arcutis Biotherapeutics ARQT
NASDAQ ARQT
$23.90 +0.24 (+1.01%)
As of: Sep 4, 2026 · 3:59 PM EDT

Arcutis Biotherapeutics (ARQT) EPS (Diluted) (2019 - 2026)

Analysis

Arcutis Biotherapeutics (ARQT) EPS (Diluted) (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 12.23
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 7.15
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -1.96
5 Revolution Medicines 44.33 Bn 44.33 Bn - -3.06
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 2.05
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.19
8 Royalty Pharma 28.45 Bn 27.61 Bn - 0.15
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -0.06
10 Arcutis Biotherapeutics 3.12 Bn 2.88 Bn 118.92 Mn 0.11
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.11
Mar 31, 2026 -0.09
Dec 31, 2025 0.14
Sep 30, 2025 0.06
Jun 30, 2025 -0.13
Mar 31, 2025 -0.20
Dec 31, 2024 -0.09
Sep 30, 2024 -0.33
Jun 30, 2024 -0.42
Mar 31, 2024 -0.32
Dec 31, 2023 -0.96
Sep 30, 2023 -0.73
Jun 30, 2023 -1.16
Mar 31, 2023 -1.31
Dec 31, 2022 -1.31
Sep 30, 2022 -1.89
Jun 30, 2022 -1.32
Mar 31, 2022 -1.29
Dec 31, 2021 -1.45
Sep 30, 2021 -1.14